Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009863 |
---|---|
Receipt number | R000011558 |
Scientific Title | Mapping of brain tau deposition in tauopathy by PET with [11C]PBB3 |
Date of disclosure of the study information | 2013/02/14 |
Last modified on | 2022/08/02 12:43:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/24 18:48:10 | ||
2 | Update | 2014/01/24 12:00:12 | Email Last name of contact person Last name of contact person TEL |
|
3 | Update | 2014/07/24 09:58:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
4 | Update | 2014/07/24 10:01:50 | Condition Condition Primary outcomes |
|
5 | Update | 2017/08/28 08:27:11 | Recruitment status |
|
6 | Update | 2021/12/15 19:06:27 | Basic design No. of arms Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Interventions/Control_3 Interventions/Control_4 Interventions/Control_4 Interventions/Control_5 Interventions/Control_5 Interventions/Control_6 Interventions/Control_6 |
|
7 | Update | 2021/12/15 19:11:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Category of Funding Organization Email1 Organization Organization Address Address Tel |
|
8 | Update | 2022/08/02 12:31:57 | Number of participants that the trial has enrolled |
|
9 | Update | 2022/08/02 12:35:11 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
10 | Update | 2022/08/02 12:43:36 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |